
USANA HEALTH SCIENCES INC
USNANYSETrading Snapshot
- Day Range
- $13.82 β $14.27
- 52-Week Range
- $14.19 β $32.32
- Volume
- $2.83B
- Avg Volume
- $3.59B
- Shares Outstanding
- 18.5M
- Next Earnings
- Oct 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $925M
- Last Q Revenue
- $223M
- P/E Ratio
- 32.2
- P/S Ratio
- 0.3x
- EPS (TTM)
- $0.48
- Dividend Yield
- β
Why Investors Own USNA
- βHigh-growth profile β revenue up +33.0% YoY with expanding US Equity exposure.
- βHealthy economics β 33% gross margin and 17% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About USANA HEALTH SCIENCES INC
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
USANA HEALTH SCIENCES INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift USNA price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
USANA HEALTH SCIENCES INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.